U.S. Treasury yields have seen significant fluctuations, with the 10-year yield rising over 90 basis points in 2026 and reaching a high of more than 5.3%, while the 30-year yield hit 5.7%, the highest in 24 years.
This volatility is raising concerns about potential further rate hikes by the Federal Reserve, especially after consumer prices increased by 3.7% year-over-year in September, exceeding expectations. As a result, traders are anticipating at least one more rate hike before the end of the year.
Higher interest rates typically create challenges for sectors with high debt and capital requirements, such as homebuilders and utilities. For instance, 38% of homebuilders reduced prices in September due to sluggish demand linked to rising mortgage rates, leading to a 7.3% drop in the iShares U.S. Home Construction ETF (ITB).
Utilities are also feeling the pressure, with the S&P 500 utilities sector experiencing a more than 6% decline in September, its largest monthly drop since December 2024. Technology stocks, particularly those involved in artificial intelligence, are also at risk as concerns grow over their borrowing levels.
The iShares Semiconductor ETF (SOXX) is facing a prolonged losing streak, reflecting broader market volatility. In contrast, healthcare stocks are expected to be more resilient due to their stable earnings and consistent demand.
Notably, Abbott Laboratories, Boston Scientific, and CVS Health are among the healthcare stocks favored by analysts, with Abbott showing a potential upside of nearly 16% from its recent close